Latest News for: gbm

Edit

NOTICE No. 8/GBM/2025 OF 9 DECEMBER – GUIDELINES FOR THE REPORTING OF TECHNOLOGICAL AND CYBER INCIDENTS (Bank of Mozambique)

Public Technologies 10 Dec 2025
) ... The provisions of the Notice apply to credit institutions and financial companies. Read the Noticehere. Attachments Original document Permalink. Disclaimer ... (noodl. 128311628) .
Edit

NOTICE No. 9/GBM/2025 OF 9 DECEMBER – ESTABLISHES LIMITS ON OVERSEAS PAYMENTS MADE USING BANK CARDS (Bank of Mozambique)

Public Technologies 10 Dec 2025
). Sets the limit on overseas payments made using bank cards ... Read the Notice here ... Disclaimer ... (noodl. 128311986) .
Edit

Black Diamond Therapeutics Announces Preliminary Phase 2 Data for Silevertinib in 1L NSCLC and Plans for a Phase 2 Trial of Silevertinib in GBM (Form 8-K) (Black Diamond Therapeutics Inc)

Public Technologies 03 Dec 2025
· Based on encouraging CNS activity of silevertinib in multiple trials across NSCLC and GBM, Company plans to initiate a randomized Phase 2 trial of silevertinib in newly diagnosed GBM patients in 1H 2026; initial data anticipated in 2028.
Edit

Imvax Announces Positive Top-line Data from Phase 2b Clinical Trial of IGV-001 in Newly Diagnosed GBM

The Galveston Daily News 02 Dec 2025
PHILADELPHIA--(BUSINESS WIRE)--Dec 2, 2025-- ....
Edit

G-SHOCK launches three new metallic variants of GBM-2100 series

The Times of India 01 Dec 2025
G-SHOCK has launched three new metallic colorways for its GBM-2100 lineup, priced at Rs 19,995 each. The new models—Champagne Gold (GBM-2100A-8B), Metallic Blue (GBM-2100A-2B), and Burgundy ...
Edit

Genenta Reports Long-Term Survival Trends and Immune Findings in Brain Tumor (GBM) Trial

Nasdaq Globe Newswire 24 Nov 2025
Genenta Reports Long-Term Survival Trends and Immune Findings in Brain Tumor Trial. Approximately $30 Million in Cash and Short-Term investments ... .
Edit

2025 Society for NeuroOncology Annual MeetingThe Tetravalent Death Receptor 5 Agonist Ozekibart (INBRX-109) in Conventional Chondrosarcoma: Results From the Randomized, Registrational, Phase 2 ChonDRAgon Study 21st Annual Industry/Academia Precision Oncology & Radmed Symposium (SNO 2025 INBRX-109 GBM Preclinical DataCTOS 2025 ChonDRAgon Primary Data Abstract Nov25Inhibrx 21st Annual Precision Oncology DR5 Agonist Clinical Data Nov25) (Inhibrx Biosciences Inc)

Public Technologies 22 Nov 2025
GBM tumor cell lines have variable in vitro sensitivities to ozekibart and TMZ as single agents but typically exhibit enhanced sensitivity to combination treatment. Glioblastoma (GBM) is the most ...
Edit

Australia’s GBM Resources plans Hong Kong secondary listing to tap wider investors

Hong Kong Standard 18 Nov 2025
Australian gold and copper explorer GBM ...
Edit

NOTICE NO. 5/GBM/2025 OF 21 OCTOBER, SUBMISSION OF STATISTICAL INFORMATION TO THE BANCO DE MOÇAMBIQUE (Bank of Mozambique)

Public Technologies 18 Nov 2025
) ... This Notice repeals Notice No. 4/GBM/2020 of 23 April, which set the previous reporting requirements. Read the Notice here(PT) ... Disclaimer ... (noodl.
Edit

NOTICE NO. 6/GBM/2025 OF 21 OCTOBER, CLIMATE RISK MANAGEMENT GUIDELINES (Bank of Mozambique)

Public Technologies 18 Nov 2025
6/GBM/2025, of 21 October approves the Climate Risk Management Guidelines, which establish the principles and procedures designed to mitigate ...
Edit

NOTICE NO. 7/GBM/2025 OF 21 OCTOBER, GUIDELINES ON EQUITABLE ACCESS TO AND USE OF FINANCIAL PRODUCTS AND SERVICES (Bank of Mozambique)

Public Technologies 18 Nov 2025
7/GBM/2025 of 21 October sets out the Guiding Principles on the Policy for Equitable Access to and Use of Financial Products and ...
Edit

Kazia Therapeutics Achieves Initial iCR (Immune-Complete Response) in Metastatic TNBC and Delivers Q4 Business Update with Breakthroughs Across Breast Cancer, Immuno-Oncology, and GBM Regulatory Strategy

PR Newswire 18 Nov 2025
GBM Program ... A completed Phase 2/3 study in glioblastoma (GBM-Agile) was reported in 2024 and discussions are ongoing for designing and executing a pivotal registrational study in pursuit of a standard approval.
Edit

Kazia Therapeutics to Request FDA Type C Meeting to Discuss Overall Survival Data in GBM and Potential NDA Filing in Alignment with FDA initiative Project FrontRunner

PR Newswire 27 Oct 2025
"GBM remains one of the most lethal cancers with limited therapeutic options ... Kazia intends to reference Project FrontRunner principles in its Type C briefing package, including an OS-driven confirmatory study plan in newly diagnosed GBM.
Edit

AI that’s secure, governed and agile; GBM looks to redefine client partnering

Tahawultech 27 Oct 2025
What are GBM’s key themes or innovations being showcased at GITEX 2025? ... What sets GBM apart is our experience ... How is GBM rethinking its workspace strategy to attract, retain and upskill top talent, especially in such a competitive market? ... GBM ....
Edit

Re-shaping data management, GBM puts confidence at the core of Enterprise AI

Tahawultech 24 Oct 2025
This reflects both our joint initiatives with IBM and our work at GBM ... Visitors to GITEX can explore how GBM solutions empower organisations to automate processes, enhance productivity, and extract actionable insights from their data.” ... GBM ....

Article Search

tools
×
×
×
×